Trials / Completed
CompletedNCT03766373
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Novus Therapeutics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Safety and Reduction of Ear Pain in Adults with Acute Otitis Media.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Drug: OP0201 20mg | OP0201 |
| COMBINATION_PRODUCT | Drug: Placebo 0mg | Placebo |
Timeline
- Start date
- 2019-01-07
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
- First posted
- 2018-12-06
- Last updated
- 2019-12-05
- Results posted
- 2019-11-21
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03766373. Inclusion in this directory is not an endorsement.